Western blotting of the cells treated as shown in Fig. 10B, analogously to the treatment of cancer cells presented in Fig. 1B, revealed that there is no strong sensitizing effect of the ActD + Nut3a combination on FASLG-induced apoptosis. The gene discussed is FASLG; the disease is cancer.